Keyphrases
Scoping Review
100%
Cisgender
100%
Voice Change
100%
Androgen Supplementation
100%
Androgens
60%
Testosterone
60%
Potential Risk
40%
Adverse Effects
20%
Postmenopausal Women
20%
Patient Selection
20%
Intramuscular Injection
20%
PubMed
20%
Minimal Impact
20%
Inclusion Criteria
20%
Mode of Delivery
20%
Structural Alterations
20%
Low Energy
20%
FDA-approved Drugs
20%
Review Method
20%
Dose Delivery
20%
Voice Quality
20%
Anabolic Steroids
20%
Dose Duration
20%
Vocal
20%
Quality Risk
20%
Safe Dose
20%
Decreased Libido
20%
Web of Science and Scopus Databases
20%
Dysphoria
20%
Reduced muscle Mass
20%
Transdermal Formulation
20%
Vocal Range
20%
Medicine and Dentistry
Androgen
100%
Supplementation
100%
Voice Change
100%
Adverse Event
16%
Patient Selection
16%
Premenopause
16%
Transdermal
16%
Intramuscular Injection
16%
Anabolic Agent
16%
Libido Disorder
16%
Dysphoria
16%
Nursing and Health Professions
Supplementation
100%
Androgen
100%
Adverse Event
16%
Medline
16%
Food and Drug Administration
16%
Scopus
16%
Patient Selection
16%
Anabolic Agent
16%
Intramuscular Drug Administration
16%
Libido Disorder
16%
Muscle Mass
16%
Dysphoria
16%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
100%
Adverse Event
16%
Intramuscular Injection
16%
Transdermal
16%
Anabolic Steroid
16%
Libido Disorder
16%
Dysphoria
16%